In a Feb. 4 letter to HOT’s board, SHCM says the company’s shares are “materially undervalued” and blasts the board’s “apparent unwillingness to respond to recent inquiries regarding potential strategic combinations.”
SHCM’s Scott Ferguson’s believes HOT is not recognizing the potential of its various products that are marketed under the Vicks, Revlon, OXO, Pert, Braun, Dr. Scholl’s, Honeywell, Duracraft and Vidal Sassoon names.
The owner of 3.7 percent of HOT shares says it had contact with the target’s former CEO Gerald Rubin, who resigned on Jan. 16. Kekst & Co. advises the hedge fund.
HOT, on Feb. 5, responded to SHCM, saying it also believes shares are undervalued and remains confident that its current strategy is the path to greater growth and profitability.
The El Paso-based company reported a 10.6 percent decline in nine-month sales to $75.2M on a 4.3 percent uptick in revenues to $1B.